Status:
TERMINATED
The Efficacy of Crotaline Fab Antivenom for Copperhead Snake Envenomations
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Snake Envenomation
Eligibility:
All Genders
12+ years
Phase:
PHASE4
Brief Summary
Most patients bitten by copperhead snakes do not currently receive antivenom. Some snakebite victims have long term problems with the function of the limb that was bitten. This study will determine wh...
Detailed Description
This study seeks to answer three important questions about the role of ovine (sheep-derived) antivenom in the treatment of people bitten by copperhead snakes (Agkistrodon contortrix): 1. Although ovi...
Eligibility Criteria
Inclusion
- Envenomation by copperhead snake (Agkistrodon contortrix) within 6 hours
- Mild or moderate severity envenomation
Exclusion
- Allergy to antivenom or components
- Severe envenomation (hypotension, severe swelling, compartment syndrome, bleeding, etc.)
- Uncertain snake ID
- Prior treatment with antivenom
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00303303
Start Date
April 1 2005
End Date
May 1 2008
Last Update
December 1 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Carolinas Medical Center
Charlotte, North Carolina, United States, 28232
2
Duke University Medical Center
Durham, North Carolina, United States, 27710
3
Richland Memorial Hospital
Columbia, South Carolina, United States, 29203
4
Medical College of Virigina/Virginia Commonwealth University Hospital
Richmond, Virginia, United States, 23298